Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

Fralex Therapeutics

Status and phase: Terminated; Phase 3

Conditions: Chronic Musculoskeletal Pain

Treatments: Device: PRIMA

Study type: Interventional

Funder types: Industry

Identifiers

NCT00253032

F05001

Details and patient eligibility

About

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria